In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

The cancer genome atlas pan-cancer analysis project

The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092 · see citing works

Cancer Genome Landscapes

Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863 · see citing works

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461 · see citing works

Network pharmacology: the next paradigm in drug discovery

Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622 · see citing works

Mutational landscape and significance across 12 major cancer types

Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419 · see citing works

ChEMBL: a large-scale bioactivity database for drug discovery

Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382 · see citing works

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers

Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634 · see citing works

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

Mermel, C. H., Schumacher, S. E., Hill, B., Meyerson, M. M., Beroukhim, R., & Getz, G. A. (2011) · Genome biology · doi:10.1186/gb-2011-12-4-r41 · Cited by 3,469 · see citing works

A census of human cancer genes

Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184 · see citing works

Discovery and saturation analysis of cancer genes across 21 tumour types

Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096 · cited 3× · see citing works

International network of cancer genome projects

The International Cancer Genome Consortium (2010) · Nature · doi:10.1038/nature08987 · Cited by 2,299 · see citing works

Lessons from the Cancer Genome

Garraway, L. A., & Lander, E. S. (2013) · Cell · doi:10.1016/j.cell.2013.03.002 · Cited by 1,322 · see citing works

Biological and therapeutic impact of intratumor heterogeneity in cancer evolution

McGranahan, N., & Swanton, C. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.12.001 · Cited by 1,077 · see citing works

Combinatorial drug therapy for cancer in the post-genomic era

Al-Lazikani, B., Banerji, U., & Workman, P. (2012) · Nature Biotechnology · doi:10.1038/nbt.2284 · Cited by 1,070 · see citing works

Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome

Davoli, T., Xu, A. W., Mengwasser, K. E., Sack, L. M., Yoon, J. C., Park, P. J., & Elledge, S. J. (2013) · Cell · doi:10.1016/j.cell.2013.10.011 · Cited by 815 · see citing works

Gene therapy clinical trials worldwide to 2012 – an update

Ginn, S., Alexander, I. E., Edelstein, M. L., Abedi, M. R., & Wixon, J. (2013) · Journal of Gene Medicine · doi:10.1002/jgm.2698 · Cited by 807 · see citing works

Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis

Malhotra, D., Portales-Casamar, É., Singh, A., Srivastava, S., Arenillas, D. J., Happel, C., Shyr, C., Wakabayashi, N., Kensler, T. W., Wasserman, W. W., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq212 · Cited by 796 · see citing works

Drugging the p53 pathway: understanding the route to clinical efficacy

Khoo, K. H., Verma, C. S., & Lane, D. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4236 · Cited by 723 · see citing works

Exploring the Genomes of Cancer Cells: Progress and Promise

Stratton, M. R. (2011) · Science · doi:10.1126/science.1204040 · Cited by 688 · see citing works

IntOGen-mutations identifies cancer drivers across tumor types

González-Pérez, A., Perez-Llamas, C., Deu-Pons, J., Tamborero, D., Schroeder, M. P., Jené-Sanz, A., Santos, A., & López-Bigas, N. (2013) · Nature Methods · doi:10.1038/nmeth.2642 · Cited by 570 · see citing works

Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine

Allen, E. M. V., Wagle, N., Stojanov, P., Perrin, D., Cibulskis, K., Marlow, S., Jané‐Valbuena, J., Friedrich, D. C., Kryukov, G. V., Carter, S. L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3559 · Cited by 533 · see citing works

OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes

Tamborero, D., González-Pérez, A., & López-Bigas, N. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt395 · Cited by 484 · see citing works

Comprehensive identification of mutational cancer driver genes across 12 tumor types

Tamborero, D., González-Pérez, A., Perez-Llamas, C., Deu-Pons, J., Kandoth, C., Reimand, J., Lawrence, M. S., Getz, G. A., Bader, G. D., Li, J., et al. (2013) · Scientific Reports · doi:10.1038/srep02650 · Cited by 475 · see citing works

The landscape and therapeutic relevance of cancer-associated transcript fusions

Yoshihara, K., Wang, Q., Torres-Garcia, W., Zheng, S., Vegesna, R., Kim, H., & Verhaak, R. G. W. (2015) · Oncogene · doi:10.1038/onc.2014.406 · Cited by 450 · see citing works

Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia

(2013) · doi:10.1158/2159-8290.cd-13-0350 · Cited by 393 · see citing works

Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group

Oza, A. M., Elit, L. M., Tsao, M., Kamel‐Reid, S., Biagi, J. J., Provencher, D. M., Gotlieb, W. H., Hoskins, P. J., Ghatage, P., Tonkin, K. S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.1578 · Cited by 344 · see citing works

Cancer drug discovery by repurposing: teaching new tricks to old dogs

Gupta, S. C., Sung, B., Prasad, S., Webb, L. J., & Aggarwal, B. B. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.06.005 · Cited by 340 · see citing works

Genomics-Driven Oncology: Framework for an Emerging Paradigm

Garraway, L. A. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.8934 · Cited by 339 · see citing works

Functional impact bias reveals cancer drivers

González-Pérez, A., & López-Bigas, N. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks743 · Cited by 328 · see citing works

Data completeness—the Achilles heel of drug-target networks

Mestres, J., Gregori‐Puigjané, E., Valverde, S., & Solé, R. V. (2008) · Nature Biotechnology · doi:10.1038/nbt0908-983 · Cited by 265 · see citing works

Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia

Ferreira, P. G., Jares, P., Rico, D., Gómez-López, G., Martínez-Trillos, A., Villamor, N., Ecker, S., González-Pérez, A., Knowles, D. G., Monlong, J., et al. (2014) · Genome Research · doi:10.1101/gr.152132.112 · Cited by 214 · see citing works

Computational approaches to identify functional genetic variants in cancer genomes

González-Pérez, A., López-Bigas, N., Mustonen, V., Ritchie, G. R. S., Butler, A. P., Dronov, S., Reva, B. A., Sander, C., Flicek, P., Creixell, P., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2562 · Cited by 171 · see citing works

A Pan-Cancer Analysis of Transcriptome Changes Associated with Somatic Mutations in U2AF1 Reveals Commonly Altered Splicing Events

Brooks, A. N., Choi, P. S., de Waal, L. M., Sharifnia, T., Imielinski, M. B., Saksena, G., Pedamallu, C. S., Sivachenko, A., Rosenberg, M. W., Chmielecki, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087361 · Cited by 171 · see citing works

A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer

Buller, R. E., Runnebaum, I. B., Karlan, B. Y., Horowitz, J. A., Shahin, M. S., Buekers, T., Petrauskas, S., Kreienberg, R., Slamon, D. J., & Pegram, M. D. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700472 · Cited by 164 · see citing works

Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms

Przychodzen, B. P., Jerez, A., Guinta, K. M., Sekeres, M. A., Padgett, R. A., Maciejewski, J. P., & Makishima, H. (2013) · Blood · doi:10.1182/blood-2013-01-480970 · Cited by 149 · see citing works

Erratum: Drugging the p53 pathway: understanding the route to clinical efficacy

Khoo, K. H., Verma, C. S., & Lane, D. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4288 · Cited by 135 · see citing works

Standardized decision support in next generation sequencing reports of somatic cancer variants

Dienstmann, R., Dong, F., Borger, D. R., Dias-Santagata, D. C., Ellisen, L. W., Le, L. P., & Iafrate, A. J. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.03.021 · Cited by 89 · see citing works

The SWI/SNF genetic blockade: effects in cell differentiation, cancer and developmental diseases

Romero, O. A., & Sánchez‐Céspedes, M. (2013) · Oncogene · doi:10.1038/onc.2013.227 · Cited by 82 · see citing works

canSAR: an integrated cancer public translational research and drug discovery resource

Halling‐Brown, M., Bulusu, K. C., Patel, M. N., Tym, J. E., & Al‐Lazikani, B. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr881 · Cited by 81 · see citing works

OncodriveROLE classifies cancer driver genes in loss of function and activating mode of action

Schroeder, M. P., Rubio-Pérez, C., Tamborero, D., González-Pérez, A., & López-Bigas, N. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu467 · Cited by 58 · see citing works

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

Charoentong, P., Finotello, F., Angelova, M., Mayer, C., Efremova, M., Rieder, D., Hackl, H., & Trajanoski, Z. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.019 · Cited by 5,041 · see citing works

A Landscape of Pharmacogenomic Interactions in Cancer

Iorio, F., Knijnenburg, T. A., Vis, D. J., Bignell, G. R., Menden, M. P., Schubert, M., Aben, N., Gonçalves, E., Barthorpe, S., Lightfoot, H., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.017 · Cited by 2,090 · see citing works

Universal Patterns of Selection in Cancer and Somatic Tissues

Martincorena, I., Raine, K. M., Gerstung, M., Dawson, K. J., Haase, K., Van Loo, P., Davies, H., Stratton, M. R., & Campbell, P. J. (2017) · Cell · doi:10.1016/j.cell.2017.09.042 · Cited by 1,523 · see citing works

Whole-genome landscapes of major melanoma subtypes

Hayward, N. K., Wilmott, J. S., Waddell, N., Johansson, P. A., Field, M. A., Nones, K., Patch, A., Kakavand, H., Alexandrov, L. B., Burke, H., et al. (2017) · Nature · doi:10.1038/nature22071 · Cited by 1,466 · see citing works

A compendium of mutational cancer driver genes

Martínez-Jiménez, F., Muiños, F., Sentís, I., Deu-Pons, J., Reyes-Salazar, I., Arnedo-Pac, C., Mularoni, L., Pich, O., Bonet, J., Kranas, H., et al. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0290-x · Cited by 1,278 · see citing works

Non-coding recurrent mutations in chronic lymphocytic leukaemia

Puente, X. S., Beà, S., Valdés‐Mas, R., Villamor, N., Gutiérrez‐Abril, J., Martín-Subero, J. I., Munar, M., Rubio-Pérez, C., Jares, P., Aymerich, M., et al. (2015) · Nature · doi:10.1038/nature14666 · Cited by 813 · see citing works

Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma

Hedegaard, J., Lamy, P., Nordentoft, I., Ferran Algaba, B., Høyer, S., Ulhøi, B. P., Vang, S., Reinert, T., Hermann, G. G., Mogensen, K., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.004 · Cited by 639 · see citing works

Precision medicine for cancer with next-generation functional diagnostics

Friedman, A. A., Letai, A., Fisher, D. E., & Flaherty, K. T. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4015 · Cited by 570 · see citing works

Mitochondrial DNA copy number variation across human cancers

Reznik, E., Miller, M. L., Şenbabaoğlu, Y., Riaz, N., Sarungbam, J., Tickoo, S. K., Al‐Ahmadie, H. A., Lee, W., Seshan, V., Hakimi, A. A., et al. (2016) · eLife · doi:10.7554/elife.10769 · Cited by 515 · see citing works

Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations

Tamborero, D., Rubio-Pérez, C., Deu-Pons, J., Schroeder, M. P., Vivancos, A. P., Rovira, A., Tusquets, I., Albanell, J., Rodon, J. A., Tabernero, J. M., et al. (2018) · Genome Medicine · doi:10.1186/s13073-018-0531-8 · Cited by 523 · see citing works

Overcoming cancer therapeutic bottleneck by drug repurposing

Zhang, Z., Zhou, L., Xie, N., Nice, E. C., Zhang, T., Cui, Y., & Huang, C. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00213-8 · Cited by 521 · see citing works

Open Targets: a platform for therapeutic target identification and validation

Koscielny, G., An, P., Carvalho‐Silva, D., Cham, J. A., Fumis, L., Gasparyan, R., Hasan, S., Karamanis, N., Maguire, M., Papa, E., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1055 · Cited by 500 · see citing works

Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine

Adir, O., Poley, M., Chen, G., Froim, S., Krinsky, N., Shklover, J., Shainsky‐Roitman, J., Lammers, T., & Schroeder, A. (2020) · Advanced Materials · doi:10.1002/adma.201901989 · Cited by 496 · see citing works

Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes

Sveen, A., Kilpinen, S. K., Ruusulehto, A., Lothe, R. A., & Skotheim, R. I. (2015) · Oncogene · doi:10.1038/onc.2015.318 · Cited by 463 · see citing works

Anticancer drug resistance: An update and perspective

Nussinov, R., Tsai, C., & Jang, H. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100796 · Cited by 395 · see citing works

Myeloid Cell-Derived Reactive Oxygen Species Induce Epithelial Mutagenesis

Canli, Ö., Nicolas, A. M., Gupta, J. R. P., Finkelmeier, F., Goncharova, O., Pesic, M. H., Neumann, T., Horst, D. A., Löwer, M., Şahin, U., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.11.004 · Cited by 364 · see citing works

Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies

Volik, S. V., Alcaide, M., Morin, R. D., & Collins, C. C. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0044 · Cited by 349 · see citing works

Cancer Drug Response Profile scan (CDRscan): A Deep Learning Model That Predicts Drug Effectiveness from Cancer Genomic Signature

Chang, Y., Park, H., Yang, H., Lee, S., Lee, K.-Y., Kim, T. S., Jung, J., & Shin, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-27214-6 · Cited by 319 · see citing works

Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma

deCarvalho, A. C., Kim, H., Poisson, L., Winn, M. E., Mueller, C., Cherba, D., Koeman, J. M., Seth, S., Protopopov, A. I., Felicella, M. M., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0105-0 · Cited by 305 · see citing works

Precision medicine for metastatic breast cancer—limitations and solutions

Arnedos, M., Vicier, C., Loi, S., Lefèbvre, C., Michiels, S., Bonnefoi, H. R., & André, F. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.123 · Cited by 317 · see citing works

Clonal evolution of chemotherapy-resistant urothelial carcinoma

Faltas, B. M., Prandi, D., Tagawa, S. T., Molina, A. M., Nanus, D. M., Sternberg, C. N., Rosenberg, J. E., Mosquera, J. M., Robinson, B. D., Elemento, O., et al. (2016) · Nature Genetics · doi:10.1038/ng.3692 · Cited by 290 · see citing works

A proteomic landscape of diffuse-type gastric cancer

Ge, S., Xia, X., Ding, C., Zhen, B., Zhou, Q., Feng, J., Yuan, J., Chen, R., Li, Y., Ge, Z., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03121-2 · Cited by 287 · see citing works

The kinome 'at large' in cancer

Fleuren, E. D. G., Zhang, L., Wu, J., & Daly, R. J. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2015.18 · Cited by 261 · see citing works

Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers

Yuan, J., Hu, Z., Mahal, B. A. V., Zhao, S. D., Kensler, K. H., Pi, J., Hu, X., Zhang, Y., Wang, Y., Jiang, J., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.08.019 · Cited by 258 · see citing works

Evolutionary Trajectories of IDHWT Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial Diagnosis

Körber, V., Yang, J., Barah, P., Wu, Y., Stichel, D., Gu, Z., Fletcher, M. N. C., Jones, D., Hentschel, B., Lamszus, K., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.02.007 · Cited by 260 · see citing works

Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling

Liang, Q., Teoh, N., Xu, L., Pok, S., Li, X., Chu, E. S., Chiu, J., Dong, L., Arfianti, A., Haigh, W. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06931-6 · Cited by 222 · see citing works

Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer

Heyn, H., Vidal, E., Ferreira, H. J., Vizoso, M., Sayols, S., Gómez, A., Morán, S., Boqué-Sastre, R., Guil, S., Martínez‐Cardús, A., et al. (2016) · Genome biology · doi:10.1186/s13059-016-0879-2 · Cited by 209 · see citing works

Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy

Lee, J., Liu, Z., Sa, J. K., Shin, S. H., Wang, J., Bordyuh, M., Cho, H. J., Elliott, O., Chu, T., Choi, S. W., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0209-6 · Cited by 204 · see citing works

A Pharmacogenomic Landscape in Human Liver Cancers

Qiu, Z., Li, H., Zhang, Z., Zhu, Z., He, S., Wang, X., Wang, P., Qin, J., Zhuang, L., Wang, W., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.07.001 · Cited by 202 · see citing works

Precision Oncology: The Road Ahead

Senft, D., Leiserson, M. D. M., Ruppin, E., & Ronai, Z. A. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.08.003 · Cited by 192 · see citing works

Precision Oncology beyond Targeted Therapy: Combining Omics Data with Machine Learning Matches the Majority of Cancer Cells to Effective Therapeutics

Ding, M. Q., Chen, L., Cooper, G. F., Young, J. D., & Lu, X. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0378 · Cited by 191 · see citing works

Circulating tumor cells: from new biological insights to clinical practice

Gu, X., Wei, S., & Lv, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01938-6 · Cited by 196 · see citing works

Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets

Karube, K., Enjuanes, A., Dlouhy, I., Jares, P., Martin‐García, D., Nadeu, F., Ordóñez, G. R., Rovira, J., Clot, G., Royo, C., et al. (2017) · Leukemia · doi:10.1038/leu.2017.251 · Cited by 180 · see citing works

Multiscale Agent-Based and Hybrid Modeling of the Tumor Immune Microenvironment

Norton, K., Gong, C., Jamalian, S., & Popel, A. S. (2019) · Processes · doi:10.3390/pr7010037 · Cited by 175 · see citing works

Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction

Wang, J., Ma, Z., Carr, S. A., Mertins, P., Zhang, H., Zhang, Z., Chan, D. W., Ellis, M. J., Townsend, R. R., Smith, R. D., et al. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.060301 · Cited by 156 · see citing works

Leveraging big data to transform target selection and drug discovery

Chen, B., & Butte, A. J. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.318 · Cited by 159 · see citing works

Evaluating the molecule-based prediction of clinical drug responses in cancer

Ding, Z., Zu, S., & Gu, J. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw344 · Cited by 155 · see citing works

Reduced mutation rate in exons due to differential mismatch repair

Frigola, J., Sabarinathan, R., Mularoni, L., Muiños, F., González-Pérez, A., & López-Bigas, N. (2017) · Nature Genetics · doi:10.1038/ng.3991 · Cited by 152 · see citing works

Harnessing big ‘omics’ data and AI for drug discovery in hepatocellular carcinoma

Chen, B., Garmire, L., Calvisi, D. F., Chua, M.-S., Kelley, R. K., & Chen, X. (2020) · Nature Reviews Gastroenterology &amp; Hepatology · doi:10.1038/s41575-019-0240-9 · Cited by 154 · see citing works

Genetic variation in human drug-related genes

Schärfe, C., Tremmel, R., Schwab, M. G., Kohlbacher, O., & Marks, D. S. (2017) · Genome Medicine · doi:10.1186/s13073-017-0502-5 · Cited by 153 · see citing works

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

Huang, K., Li, S., Mertins, P., Cao, S., Gunawardena, H. P., Ruggles, K. V., Mani, D. R., Clauser, K. R., Tanioka, M., Usary, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14864 · Cited by 146 · see citing works

Efficient Parameter Estimation Enables the Prediction of Drug Response Using a Mechanistic Pan-Cancer Pathway Model

Fröhlich, F., Kessler, T., Weindl, D., Shadrin, A., Schmiester, L., Hache, H., Muradyan, A., Schütte, M., Lim, J.-H., Heinig, M., et al. (2018) · Cell Systems · doi:10.1016/j.cels.2018.10.013 · Cited by 143 · see citing works

Impact of outdated gene annotations on pathway enrichment analysis

Wadi, L., Meyer, M., Weiser, J., Stein, L. D., & Reimand, J. (2016) · Nature Methods · doi:10.1038/nmeth.3963 · Cited by 140 · see citing works

Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer

Thomsen, M. B. H., Nordentoft, I., Lamy, P., Vang, S., Reinert, L. S., Mapendano, C. K., Høyer, S., Orntoft, T. F., Jensen, J. B., & Dyrskjøt, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-11291-0 · Cited by 135 · see citing works

Bioinformatics in translational drug discovery

Wooller, S. K., Benstead-Hume, G., Chen, X., Ali, Y., & Pearl, F. M. G. (2017) · Bioscience Reports · doi:10.1042/bsr20160180 · Cited by 134 · see citing works

CTCF shapes chromatin structure and gene expression in health and disease

Dehingia, B., Milewska, M., Janowski, M., & Pękowska, A. (2022) · EMBO Reports · doi:10.15252/embr.202255146 · Cited by 128 · see citing works

In silico saturation mutagenesis of cancer genes

Muiños, F., Martínez-Jiménez, F., Pich, O., González-Pérez, A., & López-Bigas, N. (2021) · Nature · doi:10.1038/s41586-021-03771-1 · Cited by 117 · see citing works

Epigenetic regulation in cancer

Gu, M., Ren, B., Fang, Y., Ren, J., Liu, X., Wang, X., Zhou, F., Xiao, R., Luo, X., You, L., et al. (2024) · MedComm · doi:10.1002/mco2.495 · Cited by 119 · see citing works

In silico approach in reveal traditional medicine plants pharmacological material basis

Yi, F., Li, L., Xu, L., Meng, H., Dong, Y., Liu, H.-B., & Xiao, P. (2018) · Chinese Medicine · doi:10.1186/s13020-018-0190-0 · Cited by 115 · see citing works

Integrative Analysis Defines Distinct Prognostic Subgroups of Intrahepatic Cholangiocarcinoma

Goeppert, B. F., Tóth, R., Singer, S., Albrecht, T., Lipka, D. B., Lutsik, P., Brocks, D., Baehr, M., Muecke, O., Assenov, Y., et al. (2019) · Hepatology · doi:10.1002/hep.30493 · Cited by 112 · see citing works

deepDriver: Predicting Cancer Driver Genes Based on Somatic Mutations Using Deep Convolutional Neural Networks

Luo, P., Ding, Y., Lei, X., & Wu, F.-X. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00013 · Cited by 107 · see citing works

The integrated genomic and epigenomic landscape of brainstem glioma

Chen, L. H., Pan, C., Diplas, B. H., Xu, C., Hansen, L. J., Wu, Y., Chen, X., Geng, Y., Sun, T., Sun, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16682-y · Cited by 104 · see citing works

PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data

Piñeiro-Yáñez, E., Reboiro‐Jato, M., Goméz-López, G., Perales-Patón, J., Troulé, K., Rodrı́guez, J. M., Tejero, H., Shimamura, T., Lopez-Casas, P. P., Carretero, J., et al. (2018) · Genome Medicine · doi:10.1186/s13073-018-0546-1 · Cited by 101 · see citing works

Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling

Chen, B., Wei, W., Ma, L., Yang, B., Gill, R. M., Chua, M., Butte, A. J., & So, S. K. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.039 · Cited by 100 · see citing works

OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers

Wang, T., Ruan, S., Zhao, X., Shi, X., Teng, H., Zhong, J., You, M., Xia, K., Sun, Z. S., & Mao, F. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1033 · Cited by 93 · see citing works

Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics

Ding, R., Chen, P., Rajendran, B. K., Lyu, X., Wang, H., Bao, J., Zeng, J., Hao, W., Sun, H., Wong, A. H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23379-3 · Cited by 96 · see citing works

Artificial Intelligence to Decode Cancer Mechanism: Beyond Patient Stratification for Precision Oncology

Patel, S. K., George, B., & Rai, V. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01177 · Cited by 100 · see citing works

Polypharmacology in Precision Oncology: Current Applications and Future Prospects

Antolín, A. A., Workman, P., Mestres, J., & Al‐Lazikani, B. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160923115828 · Cited by 96 · see citing works

Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era

Cheng, F., Hong, H., Yang, S., & Wei, Y. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw051 · Cited by 87 · see citing works

Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular carcinoma

Jung, S., Kim, M. S., Jung, C. K., Park, H.-C., Kim, S. Y., Liu, J., Bae, J. S., Lee, S. H., Kim, T., Lee, S. H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11922 · Cited by 86 · see citing works

Mutational patterns and regulatory networks in epigenetic subgroups of meningioma

Paramasivam, N., Hübschmann, D., Toprak, U. H., Ishaque, N., Neidert, M. C., Schrimpf, D., Stichel, D., Reuß, D., Sievers, P., Reinhardt, A., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02008-w · Cited by 83 · see citing works

Whole-Genome Sequencing in CancerPreprint

Stutheit-Zhao, E. Y., Jones, M. R., & Jones, S. J. M. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034579 · Cited by 87 · see citing works

Objective, Quantitative, Data-Driven Assessment of Chemical Probes

Antolín, A. A., Tym, J. E., Komianou, A., Collins, I., Workman, P., & Al‐Lazikani, B. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.11.004 · Cited by 81 · see citing works

A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma

Bolli, N., Li, Y., Sathiaseelan, V., Raine, K. M., Jones, D., Ganly, P. S., Cocito, F., Bignell, G. R., Chapman, M. A., Sperling, A. S., et al. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2016.72 · Cited by 80 · see citing works

In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype.

Bossi, D., Cicalese, A., Dellino, G., Luzi, L., Riva, L., D'Alesio, C., Diaferia, G., Carugo, A., Cavallaro, E. C., Piccioni, R., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1200 · Cited by 67 · see citing works

Prediction of survival and recurrence in patients with pancreatic cancer by integrating multi-omics data

Baek, B., & Lee, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-76025-1 · Cited by 77 · see citing works

Bioinformatics for precision oncology

Singer, J., Irmisch, A., Ruscheweyh, H., Singer, F., Toussaint, N. C., Levesque, M. P., Stekhoven, D. J., & Beerenwinkel, N. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx143 · Cited by 77 · see citing works

Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy

Wu, D., Wang, D. C., Cheng, Y., Qian, M., Zhang, M., Shen, Q., & Wang, X. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.11.006 · Cited by 76 · see citing works

Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterationsPreprint

Tamborero, D., Rubio-Pérez, C., Deu-Pons, J., Schroeder, M. P., Vivancos, A. P., Rovira, A., Tusquets, I., Albanell, J., Rodon, J. A., Tabernero, J. M., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/140475 · Cited by 74 · see citing works

Molecular genetics of cocaine use disorders in humans

Noèlia Fernàndez-castillo, A., Cabana‐Domínguez, J., Corominas, R., & Cormand, B. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01256-1 · Cited by 65 · see citing works

CTCF is a barrier for 2C-like reprogramming

Olbrich, T., Vega-Sendino, M., Tillo, D., Wu, W., Zolnerowich, N., Pavani, R., Tran, A. D., Domingo, C. N., Franco, M., Markiewicz-Potoczny, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25072-x · Cited by 63 · see citing works

Computational approaches for modeling and structural design of biological systems: A comprehensive review

Gayathiri, E., Prakash, P., Kumaravel, P., Jayaprakash, J., Ragunathan, M. G., Sankar, S., Pandiaraj, S., Thirumalaivasan, N., Thiruvengadam, M., & Rajakumar, G. (2023) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2023.08.002 · Cited by 69 · see citing works

Advancing precision oncology with AI-powered genomic analysis

Srivastava, R. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1591696 · Cited by 72 · see citing works

Hepatocellular carcinoma cell lines retain the genomic and transcriptomic landscapes of primary human cancers

Qiu, Z., Zou, K., Zhuang, L., Qin, J., Li, H., Li, C., Zhang, Z., Chen, X., Cen, J., Meng, Z., et al. (2016) · Scientific Reports · doi:10.1038/srep27411 · Cited by 67 · see citing works

An Ex Vivo Platform for the Prediction of Clinical Response in Multiple Myeloma

Silva, A., Silva, M. C., Sudalagunta, P. R., Graeter, A. I., Jacobson, T., Collins, A., Nguyen, T., Song, J., Chen, D., Chen, L., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0502 · Cited by 66 · see citing works

Cancer subtype identification using somatic mutation data

Kuijjer, M. L., Paulson, J. N., Salzman, P., Ding, W., & Quackenbush, J. F. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0109-7 · Cited by 67 · see citing works

In silico approaches for screening molecular targets in Candida albicans: A proteomic insight into drug discovery and development.

Silva, D. R., Sardi, J. D. C. O., Freires, I. A., da Silva, A. C. B., & Rosalen, P. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.10.016 · Cited by 54 · see citing works

Genome Sequencing during a Patient’s Journey through Cancer

Nangalia, J., & Campbell, P. J. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1910138 · Cited by 66 · see citing works

Predicting cancer type from tumour DNA signatures

Soh, K. P., Szczurek, E., Sakoparnig, T., & Beerenwinkel, N. (2017) · Genome Medicine · doi:10.1186/s13073-017-0493-2 · Cited by 64 · see citing works

Lung Cancer Nanomedicine: Potentials and Pitfalls

Bölükbas, D. A., & Meiners, S. (2015) · Nanomedicine · doi:10.2217/nnm.15.155 · Cited by 61 · see citing works

Evaluation and consequences of heterogeneity in the circulating tumor cell compartment

Brouwer, A., Laere, B. D., Peeters, D. J. E., Peeters, M., Salgado, R., Dirix, L. Y., & Laere, S. V. (2016) · Oncotarget · doi:10.18632/oncotarget.8015 · Cited by 62 · see citing works

DrugSig: A resource for computational drug repositioning utilizing gene expression signatures

Wu, H., Huang, J., Zhong, Y., & Huang, Q. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177743 · Cited by 60 · see citing works

Precision medicine needs pioneering clinical bioinformaticians

Goméz-López, G., Dopazo, J., Cigudosa, J. C., Valencia, A., & Al‐Shahrour, F. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx144 · Cited by 60 · see citing works

From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards

Perera‐Bel, J., Hutter, B., Heining, C., Bleckmann, A., Fröhlich, M., Fröhling, S., Glimm, H., Brors, B., & Beißbarth, T. (2018) · Genome Medicine · doi:10.1186/s13073-018-0529-2 · Cited by 60 · see citing works

PRL3-zumab, a first-in-class humanized antibody for cancer therapy

Thura, M., Al-Aidaroos, A. Q., Yong, W. P., Kono, K., Gupta, A. K., Lin, Y. B., Mimura, K., Thiery, J. P., Goh, B. C., Tan, P. B. O., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.87607 · Cited by 58 · see citing works

iCAGES: integrated CAncer GEnome Score for comprehensively prioritizing driver genes in personal cancer genomes

Dong, C., Guo, Y., Yang, H., He, Z., Liu, X., & Wang, K. (2016) · Genome Medicine · doi:10.1186/s13073-016-0390-0 · Cited by 54 · see citing works

Whole-Exome Sequencing Reveals Frequent Mutations in Chromatin Remodeling Genes in Mammary and Extramammary Paget’s Diseases

Zhang, G., Zhou, S., Zhong, W., Hong, L., Wang, Y., Lu, S., Pan, J., Huang, Y., Su, M., Crawford, R. I., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.08.030 · Cited by 56 · see citing works

The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets

Knol, J. C., Lyu, M., Böttger, F., Monteiro, M. N., Pham, T. V., Rolfs, F., Vallés‐Martí, A., Schelfhorst, T., Haas, R. R. D. G., Bijnsdorp, I. V., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.05.003 · Cited by 59 · see citing works

Non-coding genetic variation in cancer

Cuykendall, T. N., Rubin, M. A., & Khurana, E. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2016.12.017 · Cited by 55 · see citing works

The whole-genome panorama of cancer driversPreprint

Sabarinathan, R., Pich, O., Martincorena, I., Rubio-Pérez, C., Juul, M., Wala, J. A., Schumacher, S. E., Shapira, O., Sidiropoulos, N., Waszak, S. M., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/190330 · Cited by 55 · see citing works

Oncogenomic portals for the visualization and analysis of genome-wide cancer data

Klonowska, K., Czubak, K., Wojciechowska, M., Handschuh, L., Żmieńko, A., Figlerowicz, M., Dams‐Kozlowska, H., & Kozłowski, P. (2015) · Oncotarget · doi:10.18632/oncotarget.6128 · Cited by 55 · see citing works

A network-based drug repositioning infrastructure for precision cancer medicine through targeting significantly mutated genes in the human cancer genomes

Cheng, F., Zhao, J., Fooksa, M., & Zhao, Z. (2016) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocw007 · Cited by 55 · see citing works

Spatial and temporal clonal evolution during development of metastatic urothelial carcinoma

Thomsen, M. B. H., Nordentoft, I., Lamy, P., Høyer, S., Vang, S., Hedegaard, J., Borre, M., Jensen, J. B., Orntoft, T. F., & Dyrskjøt, L. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.08.003 · Cited by 54 · see citing works

Advances in targeted and immunobased therapies for colorectal cancer in the genomic era

Seow, H. F., Yip, W. K., & Fifis, T. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s95101 · Cited by 52 · see citing works

OncoOmics approaches to reveal essential genes in breast cancer: a panoramic view from pathogenesis to precision medicine

López‐Cortés, A., Paz‐y‐Miño, C., Guerrero, S. X., Cabrera‐Andrade, A., Barigye, S. J., Munteanu, C. R., González‐Díaz, H., Pazos, A., Pérez‐Castillo, Y., & Tejera, E. (2020) · Scientific Reports · doi:10.1038/s41598-020-62279-2 · Cited by 55 · see citing works

Whole-exome sequencing identifies recurrent AKT1 mutations in sclerosing hemangioma of lung

Jung, S., Kim, M. S., Lee, S. H., Park, H.-C., Choi, H. J., Maeng, L.-S., Min, K. O., Kim, J., Park, T. I., Shin, O. R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606946113 · Cited by 51 · see citing works

Systematic Prioritization of Druggable Mutations in ∼5000 Genomes Across 16 Cancer Types Using a Structural Genomics-based Approach

Zhao, J., Cheng, F., Wang, Y., Arteaga, C. L., & Zhao, Z. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.053199 · Cited by 50 · see citing works

Public data and open source tools for multi-assay genomic investigation of disease

Kannan, L., Ramos, M., Re, A., El-Hachem, N., Safikhani, Z., Gendoo, D. M. A., Davis, S. R., Gómez-Cabrero, D., Castelo, R., Hansen, K. D., et al. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbv080 · Cited by 50 · see citing works

Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancy

Veeramachaneni, R., Walker, T. D. J., Revil, T., de Weck, A., Badescu, D., O’Sullivan, J., Higgins, C. L., Elliott, L., Liloglou, T., Risk, J. M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48229-7 · Cited by 49 · see citing works

Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center

Ortiz, M. V., Kobos, R., Walsh, M. F., Slotkin, E. K., Roberts, S. S., Berger, M. F., Hameed, M., Solit, D. B., Ladanyi, M., Shukla, N. N., et al. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26002 · Cited by 48 · see citing works

Abstract 2983: In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals novel targeting opportunities

Rubio-Pérez, C., Tamborero, D., Schroeder, M. P., Antolín, A. A., Deu-Pons, J., Perez-Llamas, C., Mestres, J., González-Pérez, A., & López-Bigas, N. (2015) · Cancer Research · doi:10.1158/1538-7445.am2015-2983 · Cited by 2 · see citing works

Abstract A1-45: In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals novel targeting opportunities

Rubio-Pérez, C., Tamborero, D., Schroeder, M. P., Antolín, A. A., Deu-Pons, J., Perez-Llamas, C., Mestres, J., González-Pérez, A., & López-Bigas, N. (2015) · Cancer Research · doi:10.1158/1538-7445.transcagen-a1-45 · Cited by 4 · see citing works

Seek and Destroy: Relating Cancer Drivers to Therapies

Martínez-Ledesma, E., de Groot, J., & Verhaak, R. G. W. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.011 · Cited by 5 · see citing works

Advancing precision medicine in silico

Cully, M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4619 · Cited by 9 · see citing works

Personalized cancer medicines

Bhardwaj, A. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa9872